INTRODUCTION
Babesiosis of dogs is a tick-transmitted intracellular haemoprotozoal disease that is commonly diagnosed at the Onderstepoort Veterinary Academic Hospital (OVAH) and accounts for approximately 11 % of hospital admissions each year 29 . Canine babesiosis is caused by Babesia gibsoni and Babesia canis 31 . In South Africa it is the subtype Babesia canis rossi that causes disease 31 . Thrombocytopaenia is well described in animal 3, 6, 23, 27, 31, 34, 35 (and specifically canine 7, 17, 20, 21, 32 ) babesiosis. Thrombocytopaenia is also associated with other haemoprotozoal diseases, such as malaria 8 and trypanosomosis 25 . It is unknown whether thrombocytopaenia is associated with the degree of red blood cell parasitaemia or severity of disease in babesiosis. While it appears that the degree of anaemia, and severity of disease, is not determined by the level of parasitaemia in natural expression of B. c. rossi 10 , others have found an association between the parasitaemia and B. c. rossi disease severity 26 , although the same authors could not find such an association in B. c. canis. There is a small experimental study that showed an association between peak babesia parasitaemia and thrombocytopaenia in dogs co-infected with Ehrlichia canis 32 . There are also limited data that suggest that the severity of disease influences the degree of thrombocytopaenia 21 . Thrombocytopaenia is commonly recognised at the OVAH in dogs with babesiosis and is often severe, with thrombocyte counts lower than 50 × 10 9 / being common 24 . This does not appear to be the case for Babesia infections in cats 27 . Babesiosis is easily diagnosed by identifying the Babesia canis parasites on thin blood film stained with a Romanowskitype stain and should not provide a diagnostic dilemma. Red blood cell parasitaemia varies from minimal to grossly obvious 10 . However, on occasions, patients present with clinical signs typical of babesiosis 9 (fever with pale mucus membranes, anaemia, splenomegaly, listlessness) and are suspected to be infected with B. canis, but where the diagnosis cannot be confirmed on multiple thin blood smear evaluation. In these patients, it is possible that the parasitaemia is very low or the patient is presented before the presence of significant parasitaemia. Such patients must then be closely monitored and repeat blood film evaluations periodically performed. While polymerase chain reaction (PCR) assay is the gold standard for confirming a diagnosis of subclinical canine babesiosis in the absence of visible parasitaemia 17 , this diagnostic test may not be available and is potentially unhelpful by virtue of the time delay while awaiting results. It would be beneficial to have a test that could help predict whether these borderline cases have B. canis infections or not, thereby providing ease of mind to both owner and clinician that this potentially acutely fatal disease is not present. It has been the subjective assessment of the clinicians at the OVAH that in the absence of thrombocytopaenia, babesiosis is unlikely (i.e. the assumption of a high predictive value of a negative result has been used intuitively).
The predictive value of a negative test result is the probability of the disease being absent with a negative test. This value is dependent on the sensitivity and prevalence of the disease and is calculated as the number of true negative test results as a proportion of all negative test results. Receiver operator characteristic (ROC) curves graphically display the full spectra of true positive ratios (sensitivity), relative to the false positive ratio (1-specificity), for a particular test and are usually used to compare different tests employed to diagnose a condition 11 . The body's response to a low platelet count is to release larger platelets into circulation 14 . In cases where bone marrow response is optimised to replace increased platelet loss, the mean platelet volume (MPV) is therefore expected to increase. Where bone marrow response to thrombocytopaenia is delayed, MPV is expected to be lower (but probably within the normal reference range) as the circulating platelets were released into circulation before thrombocytopenic stimulation for the production of larger platelets.
The objective of this study was firstly to describe quantitatively the thrombocytopaenia seen in South African canine babesiosis by a retrospective analysis of platelet counts and MPVs and comparing them with the counts and MPVs in dogs without babesiosis. Secondly, to determine whether thrombocyte counts can provide clinically useful diagnostic information. Thirdly, to investigate whether an association between red blood cell parasitaemia and thrombocyte count exists.
MATERIALS AND METHODS
The database from the Clinical Pathology section, Department of Companion Animal Clinical Studies, that serves the OVAH, University of Pretoria, was retrospectively analysed for the period 1996 to 2002. All dogs for which thrombocyte counts were obtained from full blood counts (performed on a Cell-Dyn 3500 (1996-1999) or 3700 (1999) (2000) (2001) (2002) , Abbott Laboratories, Santa Clara, USA) were included in the study. Full blood counts (on blood collected in EDTA) are routinely performed at the OVAH, primarily on those patients that are admitted to the hospital for further care or diagnostic evaluation. Approximately 60 % of dogs diagnosed with babesiosis are treated as outpatients 29 and only a limited number of these cases had full blood counts (FBC) performed. The above database therefore represents mainly cases that were deemed ill enough to admit. A diagnosis of babesiosis was made on finding Babesia canis parasites on thin blood film (peripheral capillary, or more rarely, venous blood), stained with a Romanowski-type stain (Rapidiff, Clinical Sciences Diagnostics, South Africa) and examined under ×1000 magnification by light microscopy. The platelet count of dogs diagnosed with babesiosis (Babesiosis group) was compared with all other canine patients for which a thrombocyte count was available (Non-babesiosis group), including both healthy dogs and dogs ill with disease, other than babesiosis. Only the first FBC was included in those cases that had multiple counts within a 2-week period. Dogs for which a blood film evaluation was positive for babesiosis 2 weeks or more after the initial diagnosis and treatment, were assumed to be reinfected or relapsed, and their data were included in the study.
Mean platelet volume data/response patterns were also evaluated. Only dogs with platelet counts below the laboratory's reference range (250-500 × 10 9 / ) were included in the MPV analysis, as the release of larger platelets into circulation is expected to occur during thrombocytopaenia.
Subjective assessment of B. canis parasitaemia (graded from 1-5) was available for some of the dogs in the Babesiosis group and was performed by the haematology laboratory technicians on duty at the time that the FBC was performed.
Statistical analysis
The Kolmogorov-Smirnov test was used to test for normality. Non-parametric data were compared using the Mann-Whitney rank sum test (P < 0.001) for pairwise comparisons and the Kruskal-Wallis 1-way ANOVA on ranks for multiple group comparisons. The significance level, P, was set at 0.001. Statistical analyses were performed using SigmaStat (Jandel Corporation, Chicago). The ROC was plotted in Excel (Microsoft Corporation, Redmond, USA).
Four statistical analyses were conducted: 1) descriptive and comparative statistics were performed on the 2 groups of dogs (Babesiosis and Non-babesiosis) for both thrombocyte counts and 2) MPV; 3) the sensitivity and specificity of using thrombocyte counts for diagnostic purposes by ROC analysis; 4) evaluation of the association between parasitaemia and the thrombocyte count.
RESULTS
There were 11 970 canine FBC records with thrombocyte counts: 1162 in the Babesiosis group and 10808 in the Non-babesiosis group. Of the records in the Babesiosis group, 600 (52 %) had parasitaemia scores. There were 130 MPV results for the Babesiosis group, and 1422 for the Non-babesiosis group (for which the platelet counts were <250 × 10 9 / ). The low number of MPV results is due to the Cell-Dyn analyser not providing MPV data in cases where the platelet histogram did not meet the expected non-log normal distribution (Cell-Dyn 3700 Manual, November 2000, Abbott Laboratories, Santa Clara, USA).
Thrombocyte counts
A frequency distribution of the thrombocyte counts showed a trimodal distribution in the Non-babesiosis group compared to a bimodal distribution in the Babesiosis group, but with a strong positive skewness (Fig. 1) . The distribution patterns for both groups in the thrombocytopenic range were remarkably similar. The modes for the 2 groups were: 10, 40, 300 and 10, 35 × 10 9 / thrombocytes, respectively, there being essentially no cases in the Babesiosis group to produce a recognisable distribution pattern for counts >150. The thrombocyte count distribution for both groups failed the test for normality.
Babesiosis group: the platelet count ranged from 0 to 721 × 10 9 / . The median was 14 × 10 9 / (mean was 34.6 × 10 9 / ). Ninety nine percent (1148/1162) of the babesiosis dogs had a thrombocyte count below the lower reference range value (250 × 10 9 / ). Sixty two percent of thrombocyte counts were lower than 25 × 10 9 / . Non-babesiosis group: the thrombocyte count range was 0 to 1429 × 10 9 / , with a median of 282 × 10 9 / (mean of 288 × 10 9 / ). Forty percent of the patients had a thrombocyte count below the reference range and 7 % of thrombocyte counts were lower than 25 × 10 9 / . There was a statistically significant difference in the median thrombocyte count between the 2 groups.
Mean platelet volume
Babesiosis group: the MPV data were normally distributed. The MPV ranged from 6.7-16.4 fl, with both a mean and median of 11.1 fl. The standard deviation was 1.7 fl.
Non-babesiosis group: the MPV data failed the test for normality. The MPV ranged from 4.2-22.7 fl and had a median of 9.7 fl (mean 10.2 fl).
There was a statistically significant difference in the median MPV between the 2 groups. Linear regression analysis with MPV on platelet counts was performed (Fig. 2) . The Babesiosis group had a weak correlation with a positive regression line (R = 0.170), although there was insufficient power (Power =0.49, alpha = 0.05) to draw any conclusions. The Nonbabesiosis group had a weak (although significant) correlation, with a negative slope of the MPV on platelet count regression line (R = 0.219, Power =1).
Sensitivity and specificity
A ROC was plotted for the range of thrombocyte counts that would be diagnostic for babesiosis (Fig. 3) . For a sensitivity of 95 %, the thrombocyte count was 110 × 10 9 / . At the lower end of the reference range (250 × 10 9 / ), sensitivity was 99 %. The negative predictive values for babesiosis were 99.3 % and 99.8 % at a thrombocyte counts of 110 and 250 × 10 9 / , respectively, while the positive predictive values were 35.6 % and 20.1 %, respectively.
Parasitaemia
The parasitaemia was subjectively quantified from 1 to 5 (least to most) in 600 cases (Ngroup=number of FBC in parasitaemia group: N1=196; N 2 =230; N3=96; N 4 =51; N 5 =27). None of the 5 groups were distributed normally. The median thrombocyte counts were 16.4, 10.8, 13.5, 9.0 and 8.6 × 10 9 / , respectively (Fig. 4) . The ANOVA demonstrated a statistically significant difference in the median values among the 5 groups. No assessment of the parasitaemia was made in the remaining 562 patients. A comparison between the pooled group of 600 patients and the non-scored group, showed a significant difference in the median value: 12.3 and 17.0 × 10 9 / respectively.
DISCUSSION
The Babesiosis group accounted for 9.5 % of all the FBC counts performed, which is similar to the previously reported 11 % incidence 29 of canine babesiosis at the OVAH. The reference range for thrombocytes in dogs at the Clinical Pathology laboratory is 250-500 × 10 9 / . Ninety-nine percent (1148/1162) of patients in the Babesiosis group had a platelet count lower than 250 × 10 9 / and this is in agreement with the literature in that dogs with babesiosis are thrombocytopenic 17, 20, 32 . These results also support the subjective assessment that the majority of canine babesiosis cases at the OVAH are thrombocytopenic and provides objective prevalence data. Dogs with babesiosis had significantly fewer thrombocytes than the Non-babesiosis group. Sixty two percent of thrombocyte counts in the Babesiosis group were lower than 25 × A B 10 9 / , supporting the 2nd observation that severe thrombocytopaenia is common in canine babesiosis diagnosed at the OVAH. There is some evidence in the literature that the severity of disease may influence the degree of thrombocytopaenia. In 1 study, dogs with mild B. canis infections were less thrombocytopenic than those with severe clinical disease 21 . Babesia gibsoni infections cause less severe disease than B. canis 31 . In a B. gibsoni study 17 , thrombocytopaenia was present, but with a mean value that was far higher than this study's results (mean: 155 × 10 9 / , range: 35-375 × 10 9 / ). Only 1 of the 18 dogs in that study 17 was clinically ill at the time of diagnosis. Thrombocytopaenia in the absence of visible parasitaemia may occur. Eight of the 18 polymerase chain reaction assay (PCR) B. gibsoni-positive dogs were microscopically negative on blood smear evaluation 17 . The incidence and severity of thrombocytopaenia may be species dependent. In cats infected with Babesia felis 27 , thrombocytopaenia appears to be an inconsistent finding and was confirmed to be present in only 25 % of cats, unlike the 99 % prevalence found in this population.
The median (and mean) MPV in the Babesiosis group was greater than our laboratory's reference range (6-10 fl) as well as greater than the median of the Non-babesiosis group. Similar findings have been reported elsewhere in babesiosis 17 and malaria 4, 13 . It suggests that the body is responding to the thrombocytopaenia with release of larger platelets. It is surprising that the MPV of the Non-babesiosis group was within reference range, as thrombocytopaenia should stimulate the release of platelets with larger volumes 14 . The negative MPV-thrombocyte regression line of the Non-babesiosis group does, however, reflect this as one would predict. The apparent contradiction is probably due to the large spread of platelet sizes (Fig. 2) , and that these data represent a multitude of disease processes. Similarly, one would expect a negative regression line in the Babesiosis group, which was not the case (Fig. 2) . However, there was insufficient statistical power to be certain of these results.
The thrombocyte counts proved to be remarkably sensitive for babesiosis. The ROC was employed in this report to graphically display the sensitivity and specificity of using thrombocytopaenia as a diagnostic test for babesiosis. The sensitivity was 95 % at a thrombocyte threshold value of 110 × 10 9 / . At the lower end of the reference range (250 × 10 9 / ), the sensitivity was 99 %. At thrombocyte threshold values of 110 × 10 9 / and 250 × 10 9 / , the negative predictive value was 99.3 % and 99.8 %, respectively. Therefore, at platelet counts of above 250 × 10 9 / , one is 99.8 % certain (at the prevalence of babesiosis at the OVAH) that babesiosis is not present, and another cause for illness should be sought. While the disease is common at the OVAH, in other parts of the world it is rare. Thrombocytopaenia is not specific for babesiosis and therefore the obsevation does not assist in making a diagnosis of babesiosis 15 , nor helps differentiate it from dogs with thrombocytopaenia caused by other diseases such as ehrlichiosis or immune-mediated conditions. This is reflected by the low positive predictive values (35.6 % and 20.1 % at thrombocyte counts of 110 and 250 × 10 9 / , respectively) and is graphically illustrated in the histograms for both groups (Fig. 1) . At the thrombocytopenic tail of the histogram, the Babesiosis and Non-babesiosis groups are remarkably similar. Thrombocytopaenia will need to precede diagnostically significant parasitaemia (i.e. B. canis seen on blood smear), if the negative predictive value is to be diagnostically helpful. This does appear to be the case 17 , but may not always be so. In a study of bovine babesiosis, thrombocytosis was seen initially after experimental infection with Babesia bovis, before thrombocytopaenia was noted 34 . However, these patients were splenectomised and the trial was performed soon (2 weeks) after the splenectomy. Both surgical blood loss and splenectomy can cause a reactive thrombocytosis 19 . An initial thrombocytosis was also seen in 1 B. caballi study 1 . This may explain the thrombocytosis outliers seen in the Babesiosis group. Despite this, the negative predictive value is unlikely to be challenged by these other findings. The platelet count decreased within 4 days after infection in both cited studies 1, 34 , well within the 10-21 day incubation period seen in Babesia canis infections 16 . The mechanism of the thrombocytopaenia seen in babesiosis is not clear. Falciparum malaria and babesiosis appear, to a degree, to share a common pathogenesis 2, 24 . Some of the mechanisms described for Plasmodium-induced thrombocytopaenia may therefore apply to Babesia infection. Thrombocytopaenia may result from platelet destruction (both immunological and non-immunological, and increased utilisation), increased sequestration, or decreased production 5, 33 . All 3 processes have been described in either babesiosis or malaria. The mechanism of inducing thrombocytopaenia in babesiosis may not be specific to Babesia spp., but rather to the inflammatory response that accompanies the infection 2 . It is possible, in fact even probable, that a number of the cases on which these data are based could have suffered from concurrent diseases that would also have induced thrombocytopaenia. One of the more likely of these is canine ehrlichiosis and has been reported 32 . It is, however, unlikely that all 1162 canine babesiosis cases suffered from concomitant canine ehrlichiosis or other diseases.
At platelet counts below 10-20 × 10 9 / spontaneous bleeding may occur 5, 12 . Forty-one percent of patients with babesiosis in this study had a thrombocytopaenia of <10 × 10 9 / . Clinical bleeding would be seen in most disorders that cause platelet destruction (immunemediated or consumption) to the levels of thrombocytopaenia seen in these patients. It is therefore conceivable that part of the thrombocytopaenia seen is relative, and not an absolute decrease in total body thrombocyte numbers. Studies of malaria have also demonstrated that platelets adhere to red cell membranes, resulting in apparent auto-agglutination of erythrocytes 22 and that automated blood count machines are unable to count this complex as 2 cells, resulting in a pseudothrombocytopaenia 2 8 . Clumping of thrombocytes 35 may similarly cause false low thrombocyte counts. All the cases in this study also had a blood film examined and the low platelet count was confirmed for each case. A large proportion (up to one third) of total body thrombocytes are normally stored in the spleen and are in equilibrium with circulating thrombocytes 5 . In patients with enlarged spleens, this sequestration may be excessive and cause concurrent thrombocytopaenia 5 . In such cases, however, decreased thrombocyte counts are usually only moderate and it is unlikely to be clinically significant unless other haemostatic disease processes occur concurrently 5 . Splenomegaly is usually marked in canine babesiosis and although the thrombocytopaenia seen in these patients is severe, rather than moderate, it is likely that splenic sequestration plays some role in the observed thrombocytopaenia. However, thrombocytopaenia was seen in 1 study in which splenectomised calves were experimentally infected with B. bovis 34 , suggesting that splenomegaly and sequestration may not always play a major role. Splenic sequestration, and decreased platelet half-lives, have been described in both malaria 30 and trypanosomosis 25 . Plateletmediated bleeding, seen clinically as cutaneous petechia and epistaxis, is rarely seen in canine babesiosis patients presented to the OVAH, despite the low platelet counts described above, and suggests that primary haemostatic function is probably still largely normal. This also seems to be the case in malaria 13 . However, small animal clinicians at the OVAH often report prolonged 'needleprick' bleeding in dogs with babesiosis. In 1 experimental study, babesia-infected dogs only showed excessive bleeding from ears pin-pricked for blood smear preparations 32 , with no other clinical evidence of primary haemostatic dysfunction. Another possible reason that babesia patients do not bleed spontaneously in the face of thrombocytopaenia is that although platelet numbers are low, they are still functional, which may not be the case in conditions of increased platelet destruction, such as immune-mediated thrombocytopaenia 18 . Alternatively, patients with disseminated intravascular coagulation (DIC) have other non-platelet associated coagulatory disturbances that coexist, which may synergistically result in bleeding. Disseminated intravascular coagulation manifests itself as a continuum from subclinical to fulminant, with clinical bleeding. Mild cases of babesiosis may experience some or only early changes of DIC, without the associated bleeding. Studies of malaria have demonstrated activated, but controlled coagulation activity 8 . Intravascular micro-thrombi are described in babesiosis, unassociated with clinical bleeding (i.e. severe DIC). While fulminant DIC is described in canine babesiosis 20, 21, 31 , it is likely to be present only in severe cases. Disseminated intravascular coagulation certainly may add to the cause of thrombocytopaenia, but this is unlikely to be the sole or primary mechanism.
The finding of a significant difference in the thrombocyte count in dogs with various degrees of parasitaemia was unexpected, although Van Heerden et al 32 noted, in dogs experimentally infected with Babesia canis, that thrombocyte counts often decreased at periods of peak parasitaemia. Strains of falciparum malaria, which cause more severe disease in humans, result in proportionally more platelet-mediated erythrocyte clumping 22 and may therefore be expected to cause greater thrombocytopaenia. Similarly, human patients in intensive care units (for a variety of causes) with thrombocytopaenia have been associated with a poorer prognosis 33 . In malaria, thrombocytopaenia has also been correlated with the parasitaemia 8, 13 . Severity of disease has been associated with the level of parasitaemia in B. c. rossi, but not B. c. canis 26 . Different laboratory staff subjectively assess the parasitaemia and scoring is likely to suffer from bias to some degree. In support of the latter: those groups with parasitaemia grading originated from the same population as that subgroup of patients that did not have parasitaemia scores and yet a Mann-Whitney Rank sum tests showed a significant difference between the babesiosis patients with no parasitaemia scores and a pooled group of the parasitaemia-scored animals. Further prospective studies of the affect of parasitaemia on thrombocyte counts are needed, with emphasis on eliminating bias while scoring parasitaemia.
CONCLUSIONS
Thrombocytopaenia in Babesia canisinfected dogs at the OVAH is very common, and in the majority of cases is severe, although without apparent clinical effect (bleeding diatheses). This high incidence of thrombocytopaenia can be helpful in ruling out babesiosis in those patients where the clinical signs are consistent with babesiosis, but for which a blood film evaluation is negative. Although a significant association was found between thrombocytopaenia and level of parasitaemia, significant bias may have resulted in this finding and further prospective analysis is needed to substantiate this observation. Thrombocytopaenia is probably due to a combination of factors, including concurrent disease such as canine monocytic ehrlichiosis, and explanations using only 1 mechanism may result in an incomplete understanding. Based on the differences in severity of thrombocytopaenia caused by different Babesia spp. in the same host species, it appears that the degree of thrombocytopaenia is largely determined by the pathogenicity of the parasite species and type. The 99.8 % predictive value of excluding canine babesiosis, in the absence of thrombocytopaenia, is fortuitously independent of the putative causes of thrombocytopaenia -canine babesiosis and consequent concurrent disease (such as canine ehrlichiosis) do not alter this statistic.
